Theravance Biopharma Inc


Market Cap$417.27M

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Theravance Biopharma IncTheravance Biopharma Inc-9.30%-22%8.70.2

Target Price by Analysts

142.5% upsideTheravance Biopharma Target Price DetailsTarget Price

Current Fair Value

24.2% upside

Undervalued by 24.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$417.27 Million
Enterprise Value$365.20 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.87
Outstanding Shares48,633,224
Avg 30 Day Volume309,178


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-9.32
Price to Sales8.66
Price to Book Ratio2.17
Enterprise Value to Revenue5.94
Enterprise Value to EBIT-8.87
Enterprise Value to Net Income-9
Total Debt to Enterprise0.13
Debt to Equity0.23

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Theravance Biopharma Inc

CEO: Rick Winningham